BACKGROUND: The Institute of Medicine has recommended a change in the name and criteria for Chronic Fatigue Syndrome (CFS), renaming the illness Systemic Exertion Intolerance Disease (SEID). The new SEID case definition requires substantial reductions or impairments in the ability to engage in pre-illness activities, unrefreshing sleep, post-exertional malaise, and either cognitive impairment or orthostatic intolerance. PURPOSE: In the current study, samples were generated through several different methods and were used to compare this new case definition to previous case definitions for CFS, Myalgic Encephalomyelitis (ME-ICC), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), as well as a case definition developed through empirical methods. METHODS: We used a cross-sectional design with samples from tertiary care settings, a biobank sample, and other forums. 796 patients from the US, Great Britain, and Norway completed the DePaul Symptom Questionnaire. RESULTS: Findings indicated that the SEID criteria identified 88% of participants in the samples analyzed, which is comparable to the 92% that met the Fukuda criteria. The SEID case definition was compared to a four item empiric criteria, and findings indicated that the four item empiric criteria identified a smaller, more functionally limited and symptomatic group of patients. CONCLUSION: The recently developed SEID criteria appears to identify a group comparable in size to the Fukuda et al. criteria, but a larger group of patients than the Canadian ME/CFS and ME criteria, and selects more patients who have less impairment and fewer symptoms than a four item empiric criteria.
BACKGROUND: The Institute of Medicine has recommended a change in the name and criteria for Chronic Fatigue Syndrome (CFS), renaming the illness Systemic Exertion Intolerance Disease (SEID). The new SEID case definition requires substantial reductions or impairments in the ability to engage in pre-illness activities, unrefreshing sleep, post-exertional malaise, and either cognitive impairment or orthostatic intolerance. PURPOSE: In the current study, samples were generated through several different methods and were used to compare this new case definition to previous case definitions for CFS, Myalgic Encephalomyelitis (ME-ICC), Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), as well as a case definition developed through empirical methods. METHODS: We used a cross-sectional design with samples from tertiary care settings, a biobank sample, and other forums. 796 patients from the US, Great Britain, and Norway completed the DePaul Symptom Questionnaire. RESULTS: Findings indicated that the SEID criteria identified 88% of participants in the samples analyzed, which is comparable to the 92% that met the Fukuda criteria. The SEID case definition was compared to a four item empiric criteria, and findings indicated that the four item empiric criteria identified a smaller, more functionally limited and symptomatic group of patients. CONCLUSION: The recently developed SEID criteria appears to identify a group comparable in size to the Fukuda et al. criteria, but a larger group of patients than the Canadian ME/CFS and ME criteria, and selects more patients who have less impairment and fewer symptoms than a four item empiric criteria.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: L A Jason; J A Richman; A W Rademaker; K M Jordan; A V Plioplys; R R Taylor; W McCready; C F Huang; S Plioplys Journal: Arch Intern Med Date: 1999-10-11
Authors: Michele Reyes; Rosane Nisenbaum; David C Hoaglin; Elizabeth R Unger; Carol Emmons; Bonnie Randall; John A Stewart; Susan Abbey; James F Jones; Nelson Gantz; Sarah Minden; William C Reeves Journal: Arch Intern Med Date: 2003-07-14
Authors: B M Carruthers; M I van de Sande; K L De Meirleir; N G Klimas; G Broderick; T Mitchell; D Staines; A C P Powles; N Speight; R Vallings; L Bateman; B Baumgarten-Austrheim; D S Bell; N Carlo-Stella; J Chia; A Darragh; D Jo; D Lewis; A R Light; S Marshall-Gradisnik; I Mena; J A Mikovits; K Miwa; M Murovska; M L Pall; S Stevens Journal: J Intern Med Date: 2011-08-22 Impact factor: 8.989
Authors: William C Reeves; James F Jones; Elizabeth Maloney; Christine Heim; David C Hoaglin; Roumiana S Boneva; Marjorie Morrissey; Rebecca Devlin Journal: Popul Health Metr Date: 2007-06-08
Authors: Caroline Maness; Prabhjyot Saini; Donald L Bliwise; Victoria Olvera; David B Rye; Lynn M Trotti Journal: J Sleep Res Date: 2018-04-06 Impact factor: 3.981
Authors: Leonard A Jason; Madison Sunnquist; Abigail Brown; Jacob Furst; Marjoe Cid; Jillianna Farietta; Bobby Kot; Craig Bloomer; Laura Nicholson; Yolonda Williams; Rachel Jantke; Julia L Newton; Elin Bolle Strand Journal: J Neurol Neurobiol Date: 2015-09-17
Authors: Leonard A Jason; Stephanie McManimen; Madison Sunnquist; Abigail Brown; Julia L Newton; Elin Bolle Strand Journal: J Neurol Psychol Date: 2015-11-25
Authors: Jessica A Eccles; Beth Thompson; Kristy Themelis; Marisa L Amato; Robyn Stocks; Amy Pound; Anna-Marie Jones; Zdenka Cipinova; Lorraine Shah-Goodwin; Jean Timeyin; Charlotte R Thompson; Thomas Batty; Neil A Harrison; Hugo D Critchley; Kevin A Davies Journal: Clin Med (Lond) Date: 2021-01 Impact factor: 2.659